Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Locally extensive and advanced-stage classical Hodgkin Lymphoma.
Metastatic Triple-Negative Breast Cancer (TNBC), HR+/HER2- Breast Cancer, and locally advanced or metastatic Urothelial Carcinoma.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Targeted treatment of solid tumors and hematologic malignancies.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Approved for use in oncology care according to FDA-approved indications.